Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-03-02 @ 4:02 PM
Study NCT ID:
NCT02195167
Status:
COMPLETED
Last Update Posted:
2015-03-31
First Post:
2014-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasotraline SEP360-105 Pediatric PK/PD Study
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-17
First Submit QC Date:
None
Study First Post Date:
2014-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-30
Last Update Post Date:
2015-03-31
Last Update Post Date Type:
ESTIMATED